Synthesis and structure-activity relationships of benzyloxyphenyl derivatives as a novel class of NCX inhibitors: Effects on heart failure

14Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In the context of heart failure and myocardial ischemia reperfusion, the activity of the sodium-calcium exchanger can lead to calcium overload, which in turn can lead to contractile dysfunction and arrhythmia. Therefore, NCX is an attractive target for treatment of heart failure and myocardial ischemia reperfusion. We have designed and synthesized a series of benzyloxyphenyl derivatives as potential NCX inhibitors, based on compound 4. These derivatives have been evaluated for their inhibitory activity against both the reverse and forward modes of NCX, and two novel potent NCX inhibitors (7i, 10a) were discovered. Compound 7i was evaluated for its efficacy on ouabain-induced tonotropy and arrhythmia in a heart-failure model. © 2004 Elsevier Ltd. All rights reserved.

Cite

CITATION STYLE

APA

Kuramochi, T., Kakefuda, A., Yamada, H., Ogiyama, T., Taguchi, T., & Sakamoto, S. (2005). Synthesis and structure-activity relationships of benzyloxyphenyl derivatives as a novel class of NCX inhibitors: Effects on heart failure. Bioorganic and Medicinal Chemistry, 13(3), 725–734. https://doi.org/10.1016/j.bmc.2004.10.048

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free